Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Rosalind Advisors, Inc. reported a 8.80% stake in Fennec Pharmaceuticals Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 14, 2026
Rosalind Advisors, Inc. reported a 8.80% stake in Fennec Pharmaceuticals Inc., 3,041,533 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).
- Stake
- 8.80%
- Shares
- 3,041,533
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rosalind Advisors, Inc. | 8.80% | 3,041,533 |
| SALAMON STEVEN A J | 8.60% | 2,974,867 |
| Aharon Gil | 8.60% | 2,974,867 |
| Rosalind Master Fund L.P. | 8.40% | 2,908,201 |
Source
Related
- Fennec Pharmaceuticals Inc.
- Rosalind Advisors, Inc.
- Fennec Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Rosalind Advisors, Inc. · Aug 13, 2026
- Schedule 13G/A · Rosalind Advisors, Inc. · Feb 11, 2026
- Schedule 13G · Rosalind Advisors, Inc. · Nov 13, 2025
- Schedule 13G/A · Orin Hirschman · Oct 19, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Sayad Pierre Sargis · Oct 13, 2026